180692-27-7

Basic information

• Product Name: 1-Methyl-1,2,3,6-tetrahydropyridin-4-yl trifluoroMethanesulfonate
• Synonyms: 1-Methyl-1,2,3,6-tetrahydropyridin-4-yl trifluoroMethanesulfonate
• CAS NO: 180692-27-7
• Molecular Formula: C₇H₁₀F₃NO₃S
• Molecular Weight: 245.2194096
• Mol File: 180692-27-7.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 1-Methyl-1,2,3,6-tetrahydropyridin-4-yl trifluoroMethanesulfonate(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Methyl-1,2,3,6-tetrahydropyridin-4-yl trifluoroMethanesulfonate(180692-27-7)
• EPA Substance Registry System: 1-Methyl-1,2,3,6-tetrahydropyridin-4-yl trifluoroMethanesulfonate(180692-27-7)

Safety Data

• Hazardous Substances Data: 180692-27-7(Hazardous Substances Data)

Usage

General Description

1-Methyl-1,2,3,6-tetrahydropyridin-4-yl trifluoromethanesulfonate is a complex chemical compound compound with a pyridine base. The presence of the trifluoromethanesulfonate group suggests that it is likely a salt or ester of trifluoromethanesulfonic acid. It may also be derived from the organic compound 1-methyl-1,2,3,6-tetrahydropyridin, which is a derivative of pyridine. Such compounds are often used for research purposes in various fields of chemistry, including organic synthesis and material science. However, specific information about the use, toxicity, and safety of this chemical is limited and may depend on the context in which it is used.

Upstream product

• 1445-73-4 1-Methyl-4-piperidone 
• 37595-74-7 N,N-phenylbistrifluoromethane-sulfonimide 
• 82113-65-3 bis(trifluoromethanesulfonyl)amide 

Downstream Products

• 1426802-47-2 C₂₉H₂₉F₃N₂O₄S*C₂HF₃O₂ 
• 442846-96-0 3-(1-methyl-1,2,3,4-tetrahydro-pyridin-4-yl)-5-trifluoromethyl-phenylamine 
• 453560-88-8 3-(1-methyl-1,2,3,6-tetrahydro-pyridin-4-yl)-5-trifluoromethyl-phenylamine 
• 454482-11-2 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl )-1,2,3,6-tetrahydropyridine 

Relevant articles and documents

Amino pyrimidine compound and preparation method and application thereof

The invention relates to an amino pyrimidine compound and a preparation method and application thereof. The amino pyrimidine compound has a structure as shown in a formula I. The formula is shown in the description. The compound is an inhibitor of an epidermal growth factor receptor (EGFR) kinase. The invention further relates to a medicine composition comprising the compound, a preparation methodand application thereof in preparation of anti-tumor medicines.

SUBSTITUTED ANTHRANILIC AMIDE DERIVATIVES AND METHODS OF USE

Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

Structure-activity relationship studies of flavopiridol analogues

Cyclin dependent kinases (CDKs) along with the complementary cyclins form key regulatory checkpoint controls on the cell cycle. Flavopiridol is a synthetic flavone that shows potent and selective cyclin-dependent kinase inhibitory activity. In this paper, we report modifications of the 3-hydroxy-1-methylpiperidinyl (D ring) of flavopiridol and their effect on CDK inhibitory activity. (C) 2000 Elsevier Science. All rights reserved.